|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 376.04 USD | +1.22% |
|
+2.66% | +14.89% |
| Jul. 24 | Amgen submits new data to challenge FDA's proposal to withdraw Tavneos | RE |
| Jul. 24 | CuraTeQ Biologics Wins European Medicines Agency's Positive Opinion for Neulasta Biosimilar | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 388.16 | 388.16 | 388.16 |
| Spread/Res. | -3.12% | -3.12% | -3.12% |
| Spread/Supp. | +5.85% | +16.12% | +15.31% |
| Support | 355.25 | 323.85 | 326.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
